Effects of SIMEOX on Flow and Volume

Evaluation of SIMEOX on Flow and Volume Elicited in Healthy Subjects

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03655860

Enrollment

Registered

2018-08-31

Start date

2018-09-15

Completion date

2021-12-30

Last updated

2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This study will investigate the effects of the SIMEOX (an airway clearance device) on flow and volume generated in healthy subjects

Detailed description

This is a pilot study assessing the effect of the SIMEOX device on flow and volume generated in healthy subjects. Assessment of flow and volume will be performed before and during the application of the SIMEOX. Vital capacity and expiratory flow will be assessed.

Interventions

DEVICESIMEOX

SIMEOX is a device generating a succession of gentle depression at the mouth.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Able to understand the instructions

Exclusion criteria

* Obesity (BMI \> 30kg/m²) * Active smoker * Severe scoliosis * Cardiovascular ou neuromuscular disease

Design outcomes

Primary

Measure	Time frame	Description
Change in expiratory volume	5min	Expiratory volume before and during the use of the SIMEOX will be compared
Change in expiratory volume flow rate	5min	Expiratory flow rate before and during the use of the SIMEOX will be compared

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026